RxDoctor Payments Data

Myriame Nicolas

Psychiatric/Mental Health · Vista, CANPI 1063106805

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 480 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $8,332, 3.4 times the $2,444 reported in 2023. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,366in general payments, 2019–2025

Across 480 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Johnson & Johnson$2K
  • AbbVie$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Neurocrine Biosciences, Inc.$2K
  • plus $6K from 18 others

What the payments were for

  • Food & beverage$16,17199%
  • Education$1951%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,366 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lurasidone Hcl11$6,010
Aripiprazole12$844
Quetiapine Fumarate30$343
Bupropion Hcl SrBupropion Hcl23$289
Haloperidol11$236
Hydroxyzine Hcl14$144
Gabapentin14$123
Trazodone Hcl18$117
Escitalopram Oxalate13$106
Buspirone Hcl20$105
Mirtazapine11$83
Fluoxetine Hcl21$80

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →